These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27769099)

  • 1. Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
    J Med Virol; 2017 May; 89(5):759-766. PubMed ID: 27769099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
    Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
    Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
    Tarasov SA; Zarubaev VV; Gorbunov EA; Sergeeva SA; Epstein OI
    Antiviral Res; 2012 Feb; 93(2):219-224. PubMed ID: 22178245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
    Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
    Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
    Skarnovich MA; Emelyanova AG; Petrova NV; Borshcheva AA; Gorbunov EA; Mazurkov OY; Skarnovich MO; Tarasov SA; Shishkina LN; Epstein OI
    Antivir Ther; 2017; 22(4):345-351. PubMed ID: 27924780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v].
    Shishkina LI; Skarnovich MO; Kabanov AS; Sergeev AA; Tarasov SA; Sergeeva SA; Épshteĭn ; Malkova EM; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):83-6. PubMed ID: 21446173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis and therapy of pandemic H1N1 virus infection using egg yolk antibody.
    Yang YE; Wen J; Zhao S; Zhang K; Zhou Y
    J Virol Methods; 2014 Sep; 206():19-26. PubMed ID: 24880066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection.
    Kim EH; Choi YK; Kim CJ; Sung MH; Poo H
    Virol J; 2015 Oct; 12():160. PubMed ID: 26437715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
    Chen XX; Zhou HX; Qi WB; Ning ZY; Ma YJ; Li YL; Wang GC; Chen JX
    Yao Xue Xue Bao; 2015 Aug; 50(8):966-72. PubMed ID: 26668995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-viral activity of a complex of the glycyrrhizic acid-alpha-glutamyltryptophan against the experimental lethal influenza infection in white mice caused by the oseltamivir-resistant strain of the virus].
    Smirnov VS; Garshinina AV; Shtro AA; Anikin VB; Galochkina AV; Beliavskaia SV; Zarubaev VV
    Vopr Virusol; 2014; 59(5):31-8. PubMed ID: 25895209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anti-viral activity of the complex glycyrrhizic acid-alpha-glutamyl-tryptophan against experimental lethal influenza infection in white mice caused by oseltamivir-resistant strain of the virus].
    Smirnov VS; Garshinina AV; Guseva VM; Kalinina NA; Shtro AA; Beliaevskaia SV; Anikin VB; Zarubaev VV
    Vopr Virusol; 2013; 58(5):19-26. PubMed ID: 24640167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
    Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
    Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
    Huang H; Li H; Zhou P; Ju D
    Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.
    Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H7N9 Influenza Virus Is More Virulent in Ferrets than 2009 Pandemic H1N1 Influenza Virus.
    Yum J; Ku KB; Kim HS; Seo SH
    Viral Immunol; 2015 Dec; 28(10):590-9. PubMed ID: 26421365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
    Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenomenon of released-activity. Reply on comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
    J Med Virol; 2017 Jul; 89(7):1127-1130. PubMed ID: 28036118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeopathy in disguise. Comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Dueva EV; Panchin AY
    J Med Virol; 2017 Jul; 89(7):1125-1126. PubMed ID: 28036105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.